InvestorsHub Logo
Followers 4
Posts 196
Boards Moderated 0
Alias Born 03/15/2014

Re: goosedrop post# 729

Monday, 05/12/2014 8:58:52 PM

Monday, May 12, 2014 8:58:52 PM

Post# of 8112
Very well said! Company has sophisticated products for MMJ pharma industry which typically have high entry barriers. Not just Grow Systems http://growbloxsciences.com/growblox/ but also specific Cannabis oils.
From their website:
GBS R&D Laboratories will develop and license specialized strains of medical-grade cannabis and cannabis oils for the medical consumer market. Our team of scientists will develop and acquire specialized strains for various ailments such as:
Anorexia
Arthritis
Cancer
Chronic pain
Concussions
Glaucoma
Headaches
HIV/AIDS
Insomnia
Migraines
PTSD
Seizure disorder
Stomach problems

CEO of the company seems to have good command of business and industry as seen in Milken Institute panel discussion.


Company has filed for three MMJ related licenses in Nevada that speaks volume of the capabilities of the company. http://finance.yahoo.com/news/growblox-sciences-inc-majority-controlled-130500369.html

The latest impetus being - educating smart money community through Money Show in Vegas.

As you can see key factors for a good investment are present here - good products, booming industry and sharp leadership not to mention small float. The only thing is stock need to present itself based on these factors and not be known as volatile OTC flippers' stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GBLX News